On your radar > Counterfeiting
Counterfeiting
Counterfeit medicines are now being found with unnerving frequency, even in the legitimate supply chains of developed markets such as the US and Europe. For manufacturers, regulators and other healthcare stakeholders that raises many issues, including the threat to public safety, the need to improve supply chain security and corporate accountability.
West African conference to eradicate counterfeits
24-Jul-2008 - West African states are meeting to devise a plan for cleaning up their tarnished reputations with regards to the flow of counterfeit pharmaceuticals in the region.
Four years in prison for counterfeiter
21-Jul-2008 - A man has been sentenced in the US to four years imprisonment for trafficking 38,000 counterfeit Viagra (sildenafil citrate) tablets with a wholesale value of $400,000.
Parallel traders EU counterfeiting response
30-Jun-2008 - Parallel traders have hit back at some of the EU Commission's anti-counterfeiting measures and big pharma's support for them.
Counterfeiting conference to hear of burden in developing world
26-Jun-2008 - Visiongain's third annual conference on Pharmaceutical Anti-counterfeiting Strategies kicks off next week, covering many aspects of the problem from technological deterrents, regulatory developments in the EU and US and the implications for parallel trade.
NanoEncryption anti-counterfeiting gains FDA approval
24-Jun-2008 - The US Food and Drug Administration (FDA) has approved NanoEncryption technology, a method for applying anti-counterfeit measures to dosage forms.
EU counterfeiting response is far from generic
23-Jun-2008 - Continuing in the series analysing the industries response to the EU's counterfeiting measures in-PharmaTechnologist.com tackles the generic industry's reply.
EU's API anti-counterfeiting measures insufficient
16-Jun-2008 - DSM and the European Chemical Industry Council (CEFIC) have criticised the European Commission's proposals for tackling counterfeit active pharmaceutical ingredients (APIs).
PSI reports 24% jump in counterfeits
12-Jun-2008 - Seizures of counterfeit medicines shot-up by 24 per cent in 2007, according to the latest figures from the Pharmaceutical Security Institute (PSI).
Weekly comment
Big pharma responds to EU anti-counterfeiting
09-Jun-2008 - Big pharma's responses to the European Commission's proposals for tackling counterfeiting have thrown up a diverse range of viewpoints.
EMEA ideas for preventing heparin-like contaminations
09-Jun-2008 - The European Medicines Agency (EMEA) has urged for greater international cooperation as it outlined how to prevent a repeat of the heparin crisis.
EU publishes responses to anti-counterfeit proposals
05-Jun-2008 - The European Commission has published the responses to its proposals for tackling the problem posed by counterfeit medicines.
MHRA responds to EU counterfeiting measures
22-May-2008 - UK governmental body the Medicines and Healthcare products Regulatory Agency (MHRA) has issued its response to the European Commission's proposals to tackle counterfeiting.
EFPIA sparks drug repackaging debate with counterfeiting claim
15-May-2008 - The European Federation of Pharmaceutical Industries and Associations (EFPIA) has called for a ban on the repackaging of medicines as part of a "zero tolerance" approach to the growing problem of counterfeit medicines in the region.
Spotlight
  ICH sends Q11 guidelines to EU, US & Japanese regulatorsThe ICH has sent its Q11 guidelines on APIs to regulatory bodies in the US, European Union... |
  in-Pharmatechnologist.com's review of Interphex 2012in-Pharmatechnologist.com was at Interphex 2012 in New York, US to launch the revamped version of our website and speak... |
 Effective controls still lacking for continuous processing says Interphex panelContinuous processing is still hamstrung by a lack of control systems and is not ready for specific... |
 BASF buys omega-3 maker Equateq citing pharma potentialBASF has bought omega-3 fatty acid maker Equateq, citing its pharmaceutical and dietary supplements businesses as key... |
 EMA outlines manufacturing quality docs for biologics trialsThe EMA has published final guidelines on manufacturing quality documents needed for biologics entering clinical trials. |